Treatment of substance use disorders in patients with chronic liver disease
Clinical Liver Disease · 2022-08 · 20 (2) · 66-71
DOI: 10.1002/cld.1248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Liver Disease, online erschienen am 25.08.2022. Verfasst von Manisha Verma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Einstein Healthcare Network Philadelphia Pennsylvania USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine Einstein Healthcare Network Philadelphia Pennsylvania USA.
- Departments of Psychiatry, Surgery, and Neurology University of Michigan Ann Arbor Michigan USA.
Zitieren
APA
Verma, M., & Winder, G. S. (2022). Treatment of substance use disorders in patients with chronic liver disease. Clinical Liver Disease, 20(2), 66-71. https://doi.org/10.1002/cld.1248
Vancouver
Verma M, Winder GS. Treatment of substance use disorders in patients with chronic liver disease. Clinical Liver Disease. 2022;20(2):66-71. doi:10.1002/cld.1248
BibTeX
@article{Verma2022,
author = {Verma, Manisha and Winder, Gerald Scott},
title = {Treatment of substance use disorders in patients with chronic liver disease},
journal = {Clinical Liver Disease},
year = {2022},
volume = {20},
number = {2},
pages = {66--71},
doi = {10.1002/cld.1248}
}
EUVIMED